WS #9352

The dominant narrative in this window is the de-escalation between Israel and Iran, with both sides halting attacks, corroborated by multiple sources (Bluesky, Polymarket). This counters the previous bearish oil/geopolitical risk thesis. Separately, GSK is in talks to acquire cancer biotech Nuvalent for over $9bn, a high-significance M&A event. Also, China will issue a third tranche of 15bn yuan-denominated bonds in Hong Kong on June 16, signaling ongoing fiscal activity. The Trump booing at MSG is noise for markets. The overall narrative arc is DE-ESCALATING for Middle East geopolitical risk, and STABLE for US-China tensions (no new escalation beyond prior Pentagon list).